Shanthakumar Tyavanagimatt
Senior VP & Chief Technical OfficerMr. Shanthakumar Tyavanagimatt, also known as Shantha, is Senior VP & Chief Technical Officer of Geron Corporation from October 20, 2025. Mr. Tyavanagimatt joined the Geron Corporation on October 20, 2025. He has extensive global leadership across drug development, CMC and technical operations. He has advanced oncology and antiviral programs from early development through global approval and commercialization, with a proven record of building high-performing teams and forging strong partnerships to deliver transformative therapies to patients. He served as Senior Vice President of Technical Operations at IDEAYA Biosciences, leading global CMC and supply-chain strategies and driving technical excellence, scalability and “right-first-time” regulatory approvals that enabled reliable access to new medicines. Prior to that, as Senior Vice President of Global Pharmaceutical Operations & Early Development at CTI BioPharma, he guided the company through multiple NDA and MAA approvals and established a resilient global supply network.
公司職務
- 公司名稱Geron Corporation股票代碼GERN職務Senior VP & Chief Technical Officer共事同僚
- HSHarout SemerjianCEO, President & Director
- EGElizabeth G. O'FarrellIndependent Chairman of the Board
- MJMichelle J. RobertsonEVP, CFO, Treasurer and Principal Financial & Accounting Officer
- JEJoseph Emile EidExecutive VP of Research & Development and Chief Medical Officer
- AEAhmed ElNawawiExecutive VP & Chief Commercial Officer
- SMSusan M. MolineauxIndependent Director
- DCDawn Carter BirIndependent Director
- RJRobert Jay SpiegelIndependent Director
